What are the opening hours?

Monday 7:30am - 5pm Tuesday 7:30am - 5pm Wednesday 7:30am - 5pm Thursday 7:30am - 5pm Friday 7:30am - 5pm

The Binding Site

Home
United Kingdom
Birmingham
The Binding Site

The Specialist Protein Company

Binding Site, Part of Thermo Fisher Scientific, is committed to improving patient lives worldwide through education, collaboration and innovation. Binding Site provide diagnostic solutions that help doctors, clinicians and laboratory researchers across the globe diagnose and monitor blood cancers and immune system disorders. Founded by researchers at the University of Birmingham, Binding Site has

continued to build on its strong scientific foundations, supporting research and development within our field and responding to the changing needs of patients, researchers and clinicians for over 30 years. We are committed to working in collaboration with our partners and customers to lead the way in specialized medical diagnostics, ensuring we continue to make a difference together.

11/06/2026

Electrophoretic techniques have long been the clinical standardard of how laboratories detect monoclonal proteins. However, the clinical complexity of Multiple Myeloma is highlighting the need for more sensitive and precise approaches.

Mass spectrometry offers the potential to improve detection, reduce subjectivity, and support more informed clinical decisions.

In our latest blog, we explore how mass spectrometry is shaping the future of Multiple Myeloma diagnostics.

Read more and plan your ADLM visit: https://www.thermofisher.com/bindingsite/wo/en/learning-resources/blog/thought-leadership/mass-spectrometry-myeloma-monitoring-blind-spot.html?nocache&cid=0so_fbk_10062026_PHQQPS

09/06/2026

New CME opportunity available: Multiple Myeloma & Precursor Conditions - Guidelines for Diagnosis and Surveillance

This expert-led program covers:
✔ Diagnostic testing approaches
✔ Surveillance strategies
✔ Applying current guidelines in practice

👉 Access the CME by searching “Multiple Myeloma and Precursor Conditions: Guidelines for Diagnosis and Surveillance” on Medscape: https://www.medscape.org/resource/multiple-myeloma/cme

02/06/2026

How confident are you in identifying and managing multiple myeloma?

This Medscape CME activity focuses on real-world approaches to:
• Applying guideline-based diagnostic strategies to identify multiple myeloma
• Recognizing MGUS and smoldering myeloma
• Supporting consistent patient follow-up

Featuring expert faculty from leading institutions.

Learn more: 👉 Access the CME by searching “Multiple Myeloma and Precursor Conditions: Guidelines for Diagnosis and Surveillance” on Medscape: http://spr.ly/6185B8nCB3

27/05/2026

Diagnosing multiple myeloma early and monitoring it effectively can be challenging in everyday practice.

A free new CME activity with Medscape shares practical insights on applying current guidelines for multiple myeloma and its precursor conditions, including MGUS and smoldering myeloma.

👉 Access the CME by searching “Multiple Myeloma and Precursor Conditions: Guidelines for Diagnosis and Surveillance” on Medscape: http://spr.ly/6184B8n7xC

24/04/2026

Our mission is early diagnosis of multiple myeloma. This Lab Week, make your own findings with a word search designed to test your knowledge and skills.

Download Here! https://thermofisherscientific.showpad.com/share/7L8Qgl8rTuctMdMSRoFn4

Then sharpen your pencil and let the search begin!

08/04/2026

The international guidelines for diagnosing and monitoring monoclonal gammopathies recommend serum free light chain (sFLC) values established with Freelite assays. These values cannot be assumed to apply to FLC assays produced by other manufacturers.

Learn why assay choice matters for accurate diagnosis and monitoring of monoclonal gammopathies 👉 http://spr.ly/6182B6oLBk

03/04/2026

Accurate disease monitoring depends on more than detection alone – it requires reliable quantification.

In our latest clinical case study and podcast, we discuss how conventional methods such as SPE and IFE can struggle to reliably detect and quantify M-proteins when IgA M-proteins co-migrate in the beta region.

Visit the webpage here: http://spr.ly/6184B6oYbE to listen to the podcast, and download this latest case study where we discuss this in more detail

02/04/2026

Lab Week 2026 is happening April 19-25. This year’s theme is “Lab Story: To Infinity and Beyond for Our Patients!” To us, that means monoclonal protein testing for early detection of multiple myeloma, and so, we’re excited to offer multiple P.A.C.E.®-approved presentations on the subject:

LIVE: Monoclonal Protein Testing Clinical Utility, Challenges & Opportunities (45-minute program, .5-hour credit/ Intermediate)

Tuesday, April 21st
▪️ 10:00 am PT/1:00 pm ET, Kasey Yagnik, PhD, Medical Science Liaison: https://event.eu.on24.com/wcc/r/8000195052/32BDBE37019613E8E661F78F212644C9?partnerref=facebook
▪️ 12:00 pm PT/3:00 pm ET, Stephanie Brunelle, Medical Science Liaison: https://event.eu.on24.com/wcc/r/8000194847/030E8E2EF9068B8F55032BB9A0848338?partnerref=facebook

Thursday, April 23rd
▪️ 9:00 am PT/12:00 pm ET, Kasey Yagnik, PhD, Medical Science Liaison: https://event.eu.on24.com/wcc/r/8000195060/6D29A04AA6D7B8B3A76E6D9C48B2F07C?partnerref=facebook
▪️ 11:00 am PT/2:00 pm ET, Stephanie Brunelle, Medical Science Liaison: https://event.eu.on24.com/wcc/r/8000194849/563536ECBC2B53486A08F1A81AD0ED8A?partnerref=facebook

SELF-STUDY: Monoclonal Protein Testing Clinical Utility, Challenges & Opportunities, (45-minute program, .5 credits/ Intermediate)
▪️ Presented by Bhrugu Yagnik, MS, PhD, BC-MSLcertTM: https://event.eu.on24.com/wcc/r/8000186824/F340BAE1E90B2A8D4FC5CF9767F9D6B6?partnerref=facebook

01/04/2026

In the era of modern therapeutics, is immunofixation still sensitive enough to monitor treatment response in Multiple Myeloma?

Clinical scientists in Spain have led a multicenter study showing that the EXENT® System detects low-level monoclonal protein more frequently and with greater clinical insight than immunofixation in Multiple Myeloma.

The research highlights how more sensitive methods may improve disease monitoring and response evaluation beyond traditional techniques.

Read the Scientific Short here: http://spr.ly/6185B6WbEP

31/03/2026

This March, we learned, shared, and amplified facts about multiple myeloma, from symptoms and populations at higher risk to health disparities and progress in survival.

Thank you to everyone who helped spread awareness and support the myeloma patient community.

Raising awareness is not a one-month effort. It’s an ongoing commitment. Let’s continue the conversation. Learn more about multiple myeloma and find resources at the International Myeloma Foundation here: http://spr.ly/6189hsjYv

Address

8 Calthorpe Road, Edgbaston
Birmingham
B151QT

Opening Hours

Monday	7:30am - 5pm
Tuesday	7:30am - 5pm
Wednesday	7:30am - 5pm
Thursday	7:30am - 5pm
Friday	7:30am - 5pm

Telephone

+441214569500

Website

http://www.bindingsite.com/

Alerts

Be the first to know and let us send you an email when The Binding Site posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to The Binding Site:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in Birmingham?